Haloperidol Decanoate Injection shortage
Haloperidol Decanoate Injection is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Oct 2, 2026.
Fresenius Kabi is permanently stopping production of haloperidol decanoate injection 50 mg/mL. Other makers — including Hikma, Patriot Pharmaceuticals, Sagent, and Janssen — still list both the 50 mg/mL and 100 mg/mL strengths as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Haloperidol Decanoate Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jan 9, 2026Currently in shortage2 of 2 products affected.
-
Jan 9, 2026First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Haloperidol Decanoate Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Haloperidol Decanoate Injection? options further down this page.
Why is Haloperidol Decanoate Injection in shortage?
Fresenius Kabi USA has decided to permanently stop making their version of Haloperidol Decanoate Injection 50 mg/1 mL. This affects two specific package sizes they carried (NDC 63323-469-05 and NDC 63323-469-01). They haven't shared a specific public reason for why they made this decision — just that manufacturing of this product is being discontinued.
It's worth knowing that this report only covers Fresenius Kabi's products. Other manufacturers of haloperidol decanoate may not be part of this shortage report and could have their own separate listings on the FDA shortage page.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Haloperidol Decanoate Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Haloperidol Decanoate Injection?
Haloperidol Decanoate Injection is currently listed on the FDA drug-shortage report. This note is to help you understand what that means for the strength you take.
The strength affected here is 50 mg/1 mL, which does not have an available source right now. The reason given is that the manufacturer who filed this report, Fresenius Kabi USA, is discontinuing its production of this product. Because this is listed as a discontinuation rather than a temporary delay, this particular supply problem may be permanent. That said, this report reflects only one manufacturer, and other companies make the same medicine.
Please do not let that last part worry you — this is a long-acting injection usually given by a clinician, and there are steps to keep your treatment on track.
- First, do not skip or change your dose on your own.
- Ask your pharmacy to check wholesalers and other makers; the same medicine (haloperidol decanoate injection) is listed as available from makers such as Hikma, Sagent, Janssen (Haldol Decanoate), Patriot, Caplin Steriles, and Mylan — though it may not be in local stock.
- Because this product is being discontinued, talk with your prescriber about a suitable plan, which may include the same medicine from another maker.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is general, national information and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Haloperidol Decanoate Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Haloperidol Decanoate Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 100 mg/mL | Injection · Intramuscular | Hikma Pharmaceuticals USA Inc. | 00143-9295-01 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 50 mg/mL | Injection · Intramuscular | Patriot Pharmaceuticals LLC | 10147-0921-03 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 100 mg/mL | Injection · Intramuscular | Patriot Pharmaceuticals LLC | 10147-0922-05 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 50 mg/mL | Injection, Solution · Intramuscular | Sagent Pharmaceuticals | 25021-0831-01 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 100 mg/mL | Injection, Solution · Intramuscular | Sagent Pharmaceuticals | 25021-0833-01 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 500 mg/5mL | Injection, Solution · Intramuscular | Sagent Pharmaceuticals | 25021-0834-05 |
| Haldol Decanoate | HALOPERIDOL DECANOATE 50 mg/mL | Injection · Intramuscular | Janssen Pharmaceuticals, Inc. | 50458-0253-03 |
| Haldol Decanoate | HALOPERIDOL DECANOATE 100 mg/mL | Injection · Intramuscular | Janssen Pharmaceuticals, Inc. | 50458-0254-14 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 100 mg/mL | Injection · Intramuscular | Fresenius Kabi USA, LLC | 63323-0471-01 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 100 mg/mL | Injection · Intramuscular | Caplin Steriles Limited | 65145-0167-10 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 50 mg/mL | Injection · Intramuscular | Caplin Steriles Limited | 65145-0168-10 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE 100 mg/mL | Injection · Intramuscular | Mylan Institutional LLC | 67457-0409-13 |
Therapeutic equivalents & pricing 24 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| haloperidol decanoate 50 mg/mL | Sagent | 10 vials | $6.572 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Mylan | 10 vials | $6.572 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Meitheal | 10 vials | $6.572 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Somerset | 10 vials | $6.572 | AO | Availability likely |
| Haloperidol decanoate 50 mg/mL | Zydus | 10 vials | $6.572 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Caplin | 10 vials | $6.572 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Armas | 10 vials | $6.572 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Lifestar | 10 vials | $6.572 | AO | Availability likely |
| Haloperidol decanoate 50 mg/mL | BluePoint | 3 vials | $12.052 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Fresenius | 1 vial | $12.467 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Somerset | 1 vial | $12.678 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | BluePoint | 1 vial | $12.748 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | BluePoint | 3 ampules | $20.085 | AO | FDA listed |
| Haloperidol Decanoate 50 mg/mL | Patriot | 3 ampules | $20.085 | — | FDA listed |
| Haloperidol Decanoate 50 mg/mL | Somerset | 3 ampules | $20.753 | AO | Availability likely |
| Haloperidol Decanoate 50 mg/mL | Somerset | 1 vial | — | AO | FDA listed |
| Haloperidol decanoate 50 mg/mL | Zydus | 10 vials | — | AO | FDA listed |
| Haloperidol decanoate 50 mg/mL | Zydus | 1 vial | — | AO | FDA listed |
| Haloperidol decanoate 50 mg/mL | Zydus | 1 vial | — | AO | FDA listed |
| Haloperidol Decanoate 50 mg/mL | REMEDYREPACK | 10 vials | — | AO | FDA listed |
| Haloperidol Decanoate 50 mg/mL | REMEDYREPACK | 10 vials | — | AO | FDA listed |
| Haloperidol Decanoate 50 mg/mL | Gland | 1 vial | — | AO | FDA listed |
| Haldol Decanoate 50 mg/mL | Janssen | 3 ampules | — | — | Discontinued |
| Haloperidol Decanoate 50 mg/mL | Fresenius | 1 vial | — | AO | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Haloperidol Decanoate Injection — that fall in the same broad treatment class (antipsychotics,dopamine antagonists,butyrophenones) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other psychiatry shortages
Haloperidol Decanoate Injection shortage FAQs
Is Haloperidol Decanoate Injection in shortage?
Which products are affected?
When will Haloperidol Decanoate Injection be available again?
Can I still get Haloperidol Decanoate somewhere?
What should I do if I take Haloperidol Decanoate Injection?
Still have a question about the Haloperidol Decanoate Injection shortage?
Ask a pharmacist about this shortage →View Haloperidol Decanoate Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.